CLINICAL_TRIALS
trial_result
· 2022-05-19
Clinical Trial Update: Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery [Phase 1, Phase 2]
Summary
Clinical trial update evaluating radiotherapy plus hormone therapy in biochemically-relapsing prostate adenocarcinoma after radical prostatectomy (Phase 1/Phase…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNICANCER | Conditions: Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy | Phase 1, Phase 2 | Status: COMPLETED